AngioDynamics (NSDQ:ANGO) said late yesterday that it won expanded FDA 510(k) clearance for its OARtrac radiation dose monitoring system. With the new clearance, the Latham, N.Y.-based company’s OARtrac system is cleared for use with patient-specific, pre-calibrated Plastic Scintillating Detector sensors used during cancer treatments to monitor photon and electron radiation therapy as an adjunct to treatment […]
AngioDynamics
AngioDynamics beats The Street with Q2 results
Shares in AngioDynamics (NSDQ:ANGO) rose today after the medical device maker topped expectations on Wall Street with its second quarter financial results. The Latham, N.Y.-based company posted profits of $2.1 million, or 6¢ per share, on sales of $91.5 million for the 3 months ended Nov. 30, for sales growth of 5.5% compared with the same […]
Appeals court overturns patent board in Bard spat with AngioDynamics
A federal court this week reversed a number of Patent Trial and Appeal Board rulings which invalidated patents held by Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in an ongoing patent spat with AngioDynamics (NSDQ:ANGO) . The case involves three C.R. Bard medical device patents, which in previous proceedings had had 34 of 41 claims invalidated as anticipated […]
Acquisitions hit earnings for AngioDynamics Q1
AngioDynamics (NSDQ:ANGO) took an earnings hit during its fiscal first quarter on increased acquisition expenses, but raised its sales outlook for the rest of the year. Losses grew 1,240% to -$469 million, or -1¢ per share, on flat sales of $85.3 million for the three months ended August 31. Adjusted to exclude one-time items – including […]
AngioDynamics to acquire radiation dose tech dev RadiaDyne
AngioDynamics (NSDQ:ANGO) said today that it inked a deal to acquire dose monitoring tech developer RadiaDyne for an undisclosed amount. The deal will add RadiaDyne’s early-stage OARtrac real-time radiation dose monitoring platform and its IsoLoc, ImmobiLoc and Alatus balloon stabilizing technologies to Latham, N.Y.-based AngioDynamic’s oncology portfolio, the company said. “The acquisition of RadiaDyne, combined with […]
AngioDynamics acquires Surgical Specialties’ BioSentry sealant, updates on Bard antitrust suit
AngioDynamics (NSDQ:ANGO) said today it acquired Surgical Specialties’ BioSentry Tract Sealant assets for an undisclosed amount, and touted a recent legal win in a case against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard. The newly acquired BioSentry system is designed to prevent the occurrence of pneurmothorax during CT-guided percutaneous lung biopsies using a proprietary hydrogel plug which […]
AngioDynamics nets a win in antitrust case against BD’s Bard
A federal judge in New York this week denied a motion from Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard to dismiss an antitrust lawsuit filed by AngioDynamics (NSDQ:ANGO) alleging unfair competition, according to an Albany Business Review report. AngioDynamics filed the suit against Bard last May, claiming that the larger company illegally ties the sales of its […]
AngioDynamics to pay $13m to settle False Claims charges
AngioDynamics (NSDQ:ANGO) agreed to pay a total of nearly $13 million to settle charges that it broke the False Claims Act for a chemotherapy delivery device and a peripheral vein treatment. Latham, N.Y.-based AngioDynamics distributed the LC Bead embolization microspheres made by BTG (LON:BTG) subsidiary Biocompatibles. Although cleared for embolizations, the companies allegedly marketed LC Bead from May […]
AngioDynamics CEO Clemmer is on the M&A trail
AngioDynamics (NSDQ:ANGO) CEO Jim Clemmer said the company is actively walking the M&A trail as it looks at markets with unmet needs and high margins. Latham, N.Y.-based AngioDynamics posted fiscal fourth-quarter results July 11 that missed Wall Street’s expectations, sending share prices down some -9% this week despite a swing to black ink. During a conference […]
Dynatronics taps ex-NinePoint CEO von Jako as chief exec | Personnel Moves – July 11, 2018
Dynatronics said late last month it tapped former NinePoint Medical CEO Christopher von Jako as its new chief executive officer and board member, succeeding Kelvyn Cullimore Jr. who will stay on the company’s board of directors. Prior to joining Dynatronics, von Jako acted as prez & CEO of NinePoint Medical. Before joining Nine Point, von Jako also […]
AngioDynamics takes a hit after missing Q4 numbers
AngioDynamics (NSDQ:ANGO) failed to meet expectations for its fiscal fourth quarter, sending share prices sharply down today despite a swing to black ink. Latham, N.Y.-based AngioDynamics posted profits of $2.1 million, or 6¢ per share, on sales of $88.3 million for the three months ended May 31. That compares with losses of -$12.9 million during fiscal […]